These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37191522)

  • 1. Acinetobacter Metabolism in Infection and Antimicrobial Resistance.
    Ren X; Palmer LD
    Infect Immun; 2023 Jun; 91(6):e0043322. PubMed ID: 37191522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of antimicrobial resistance among Acinetobacter species: a global threat.
    Clark NM; Zhanel GG; Lynch JP
    Curr Opin Crit Care; 2016 Oct; 22(5):491-9. PubMed ID: 27552304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections Due to Acinetobacter baumannii in the ICU: Treatment Options.
    Lynch JP; Zhanel GG; Clark NM
    Semin Respir Crit Care Med; 2017 Jun; 38(3):311-325. PubMed ID: 28578555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M; Righi E; Esposito S; Petrosillo N; Nicolini L
    Future Microbiol; 2008 Dec; 3(6):649-60. PubMed ID: 19072182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.
    Zaidan N; Hornak JP; Reynoso D
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0092421. PubMed ID: 34370576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.
    Durante-Mangoni E; Zarrilli R
    Future Microbiol; 2011 Apr; 6(4):407-22. PubMed ID: 21526942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Acinetobacter baumannii severe infections.
    Reina R; León-Moya C; Garnacho-Montero J
    Med Intensiva (Engl Ed); 2022 Dec; 46(12):700-710. PubMed ID: 36272902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii: Acinetobacter baumannii therapeutics.
    Gallagher P; Baker S
    J Infect; 2020 Dec; 81(6):857-861. PubMed ID: 33115656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections Due to Acinetobacter baumannii-calcoaceticus Complex: Escalation of Antimicrobial Resistance and Evolving Treatment Options.
    Lynch JP; Clark NM; Zhanel GG
    Semin Respir Crit Care Med; 2022 Feb; 43(1):97-124. PubMed ID: 35172361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review on potential therapeutic inhibitors of nosocomial Acinetobacter baumannii superbugs.
    Srikanth D; Joshi SV; Ghouse Shaik M; Pawar G; Bujji S; Kanchupalli V; Chopra S; Nanduri S
    Bioorg Chem; 2022 Jul; 124():105849. PubMed ID: 35594766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones.
    Mohammed MA; Ahmed MT; Anwer BE; Aboshanab KM; Aboulwafa MM
    PLoS One; 2020; 15(8):e0238195. PubMed ID: 32845920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of extensively drug-resistant
    Barrientos-Yong RS; Hinojosa-Salas BA; Salas-Ponce PG; Angles E; Ruiz J; Pons MJ
    Trop Doct; 2023 Apr; 53(2):248-255. PubMed ID: 36518018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confronting multidrug-resistant Acinetobacter baumannii: a review.
    Neonakis IK; Spandidos DA; Petinaki E
    Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
    Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
    Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological monitoring of nosocomial infections caused by acinetobacter baumannii.
    Custovic A; Smajlovic J; Tihic N; Hadzic S; Ahmetagic S; Hadzagic H
    Med Arch; 2014 Dec; 68(6):402-6. PubMed ID: 25648217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency And Clinical Spectrum Of Multidrug Resistant Acinetobacter Baumannii As A Significant Nosocomial Pathogen In Intensive Care Unit Patients.
    Sana F; Hussain A; Hussain W; Zaman G; Abbas MW; Imtiaz A; Satti L
    J Ayub Med Coll Abbottabad; 2021; 33(Suppl 1)(4):S752-S756. PubMed ID: 35077621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
    mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.